References
- Brooks BR, Sanjak M, Ringel S, England J, Brinkmann J, Pestronk A, et al. The ALS functional rating scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol. 1996;53:141–7.
- Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, etal. The ALSFRSR: a revised ALS functional rating scale that incorporates assessments of respiratory func-tion. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
- Cudkowicz ME, Titus S, Kearney M, Yu H, Sherman A, Schoenfeld D, et al. Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014;13:1083–91.
- Pinto S, de Carvalho M. The R of ALSFRS-R: does it really mirror functional respiratory involvement in amyotrophic lateral sclerosis? Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:120–3.
- Pinto S, Gromicho M, de Carvalho M. Sialorrhoea and reversals in ALS functional rating scale. J Neurol Neurosurg Psychiatry. 2017;88:187–8.
- Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91:e1370–e1380.